Marion Merrell Dow

From WikiMD's WELLNESSPEDIA

American pharmaceutical company

Marion Laboratories headquarters

Marion Merrell Dow was a major pharmaceutical company in the United States that played a significant role in the development and marketing of various medications. The company was known for its innovative approaches in the pharmaceutical industry and its contributions to healthcare.

History[edit]

Marion Merrell Dow was formed through the merger of Marion Laboratories, founded by Ewing Marion Kauffman in 1950, and Merrell Dow Pharmaceuticals, a subsidiary of Dow Chemical Company. The merger took place in 1989, creating a significant entity in the pharmaceutical sector.

Marion Laboratories[edit]

Marion Laboratories was established in Kansas City, Missouri, and quickly grew due to its focus on innovative drug development and marketing strategies. The company was known for its entrepreneurial spirit and strong corporate culture.

Merrell Dow Pharmaceuticals[edit]

Merrell Dow Pharmaceuticals was originally part of the Dow Chemical Company, focusing on the development of prescription drugs. It had a strong presence in the pharmaceutical market before merging with Marion Laboratories.

Products[edit]

Marion Merrell Dow was known for several key pharmaceutical products, including medications for cardiovascular disease, allergies, and central nervous system disorders. Some of its well-known products included Seldane (terfenadine), an antihistamine, and Cardizem (diltiazem), a drug used to treat hypertension and angina.

Acquisition and Legacy[edit]

In 1996, Marion Merrell Dow was acquired by Hoechst AG, a German chemical and pharmaceutical company, which later became part of Aventis. The acquisition marked the end of Marion Merrell Dow as an independent entity, but its legacy continued through the products and innovations it developed.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Marion_Merrell_Dow&oldid=6628856"